119 participants
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2024-04-16
- Completion:
- 2025-06-30
Conditions
- Generalized Myasthenia Gravis
- gMG
- Myasthenia Gravis, Generalized
- Myasthenia Gravis
Interventions
- BIOLOGICAL
- OTHER